Clinical Trials Directory

Trials / Unknown

UnknownNCT05309122

Cervical Cancer Screening Strategies

A Retrospective Cohort Study on the Effectiveness of Various Screening Strategies for Uterine Cervical Cancer

Status
Unknown
Phase
Study type
Observational
Enrollment
10,000 (estimated)
Sponsor
Lei Li · Academic / Other
Sex
Female
Age
18 Years
Healthy volunteers
Not accepted

Summary

This study is to investigate retrospectively the results of cervical cytology and high-risk human papillomavirus in the past 20 years recorded in Peking Union Medical College Hospital. The histological findings after cervical cancer screening were reviewed. The diagnostic values of different screening strategies were compared based on the results of cervical histology. The primary endpoint is the diagnosis of grade 2 cervical intraepithelial neoplasia (CIN2) or more severe lesions (CIN2+). The secondary endpoints include following objectives: (1) the invasive procedures needed according to the screening results; (2) the diagnosis of vaginal and/or vulval intraepithelial neoplasia; (3) the persistence and recurrence of human papillomavirus infection; and (4) the cost-effectiveness of screening strategies for CIN2+.

Conditions

Timeline

Start date
2022-03-19
Primary completion
2024-03-19
Completion
2025-03-19
First posted
2022-04-04
Last updated
2022-04-04

Locations

1 site across 1 country: China

Source: ClinicalTrials.gov record NCT05309122. Inclusion in this directory is not an endorsement.